Back
Alnylam Pharmaceuticals Stock Predictions
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
60
ALNY
Alnylam Pharmaceuticals
Last Price:
$280.77
Seasonality Move:
3.3%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the Founder That's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Alnylam Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Alnylam Pharmaceuticals has on average historically risen by 35.4% based on the past 20 years of stock performance.
-
Alnylam Pharmaceuticals has risen higher in 14 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
-
Is Alnylam Pharmaceuticals Stock Undervalued?The current Alnylam Pharmaceuticals [ALNY] share price is $290.70. The Score for ALNY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Alnylam Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Alnylam Pharmaceuticals has on average historically risen by 35.4% based on the past 20 years of stock performance.
Alnylam Pharmaceuticals Stock Rating
Buy
60
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals overpriced?
-
Alnylam Pharmaceuticals has risen higher in 14 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
Alnylam Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
alnylam.com
52-Week Data
52-Week High:
304.39
52-Week Low:
141.98
Prediction Charts
Market Cap:
37.6B
Price in USD:
290.70
Volume:
1.8M
Beta:
1.20
Technical Analysis
SMA50:
257.54
SMA100:
256.06
SMA200:
251.50
52-Wk Change:
98.42%
Stock Predictions
-
Is Alnylam Pharmaceuticals stock public?Yes, Alnylam Pharmaceuticals is a publicly traded company.
-
What is the Alnylam Pharmaceuticals stock quote today?The Alnylam Pharmaceuticals stock price is 290.70 USD today.
-
How to buy Alnylam Pharmaceuticals stock online?You can buy Alnylam Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-4 | 241.09 | 242.93 | 244.67 | 238.42 |
| Mar-5 | 243.02 | 249.23 | 249.82 | 241.55 |
| Mar-6 | 244.57 | 248.13 | 252.84 | 244.57 |
| Mar-7 | 247.14 | 244.52 | 251.12 | 240.98 |
| Mar-11 | 230.85 | 238.74 | 243.45 | 230.79 |
| Mar-12 | 241.57 | 242.43 | 246.37 | 240.39 |
| Mar-13 | 240.96 | 241.75 | 245.14 | 239.02 |
| Mar-14 | 241.51 | 241.76 | 244.04 | 239.53 |
| Mar-17 | 242.69 | 253.11 | 253.30 | 240.94 |
| Mar-18 | 254.21 | 244.30 | 263.30 | 243.87 |
| Mar-19 | 243.44 | 253.44 | 255.35 | 243.44 |
| Mar-20 | 254.09 | 253.55 | 261.90 | 252.39 |
| Mar-21 | 261.82 | 283.34 | 289.44 | 261.00 |
| Mar-24 | 288.54 | 290.70 | 300.90 | 287.77 |
Alnylam Pharmaceuticals Earnings
Alnylam Pharmaceuticals Earnings Report: Per Share Alnylam Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Alnylam Pharmaceuticals Forecast Revenue Growth
Alnylam Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Alnylam Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.